MONICA ORTEGA: Open Payments
NPI 1912282344 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 54 payments from 18 companies in 2025. Trend: 2023 $944 · 2024 $854 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $233 |
| Inspire Medical Systems, Inc. | 3 | $149 |
| REVANCE THERAPEUTICS, INC. | 1 | $106 |
| Lilly USA, LLC | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Novo Nordisk Inc | 2 | $42 |
| Acella Pharmaceuticals, LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
Products named: INSPIRE, QULIPTA, DAXXIFY, VRAYLAR, MOUNJARO, AUSTEDO XR, REXULTI, JOURNAVX.
Industry payments across NM — which companies pay providers there.
